ArticleJournal for immunotherapy of cancer2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Abstract readPublished Erratum
In one paragraph
Article in Journal for immunotherapy of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Shifting the paradigm: engaging multicellular networks for cancer therapy.Journal of translational medicine · 2024Review
- Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.Cells · 2022Review
- Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment.Cancers · 2022Review
- Hypoxia and the phenomenon of immune exclusion.Journal of translational medicine · 2021Review
- Tumor Genotype Is Shaping Immunophenotype and Responses to Immune Checkpoint Inhibitors in Solid Tumors.Journal of immunotherapy and precision oncology · 2020Review
Corrections and comments
- Erratum for
Authors and funding
56 authors.
Davide BedognettiSidra Medicine, Doha, Qatar.
Michele CeccarelliAbbVie, Redwood City, CA, USA.
Lorenzo GalluzziDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Rongze LuAbbVie, Redwood City, CA, USA.
Karolina PaluckaThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Josue SamayoaAbbVie, Redwood City, CA, USA.
Stefani SprangerKoch Institute for Integrative Cancer Research at MIT, Cambridge, MT, USA.
Sarah WarrenNanoString Technologies, Inc, Seattle, WA, USA.
Kwok-Kin WongPerlmutter Cancer Center, New York Langone Health, New York, NY, USA.
Elad ZivUniversity of California, San Francisco, CA, USA.
Diego ChowellMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Lisa M CoussensOregon Health & Science University, Portland, OR, USA.
Daniel D De CarvalhoDepartment of Medical Biophysics, Princess Margaret Cancer Centre University Health Network, University of Toronto, Toronto, Canada.
David G DeNardoWashington University School of Medicine in St. Louis, St. Louis, MO, USA.
Jérôme GalonINSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, F-75006, Paris, France.
Howard L KaufmanMassachusetts General Hospital, Boston, MA, USA and Replimune, Inc, Woburn, MA, USA.
Tomas KirchhoffPerlmutter Comprehensive Cancer Center, New York University School of Medicine, New York University Langone Health New York, New York, NY, USA.
Michael T LotzeUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Jason J LukeUniversity of Chicago, Chicago, IL, USA.
Andy J MinnAbramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA.
Katerina PolitiYale School of Medicine, New Haven, CT, USA.
Leonard D ShultzThe Jackson Laboratory Cancer Center, Bar Harbor, ME, USA.
Richard SimonR. Simon Consulting, Potomac, MD, USA.
Vésteinn ThórssonInstitute for Systems Biology, Seattle, WA, USA.
Joanne B WeidhaasUniversity of California, Los Angeles, Los Angeles, CA, USA.
Maria Libera AsciertoMedImmune, Gaithersberg, MD, USA.
Paolo Antonio AsciertoIstituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.
James M BarnesAbbVie, Redwood City, CA, USA.
Valentin BarsanStanford University, Stanford, CA, USA.
Praveen K BommareddyRutgers University, New Brunswick, NJ, USA.
Adrian BotKite, a Gilead Company, Santa Monica, CA, USA.
Sarah E ChurchNanoString Technologies, Inc, Seattle, WA, USA.
Gennaro CilibertoIRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.
Andrea De MariaUniversità degli Studi di Genova and Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
Dobrin DraganovCalidi Biotherapeutics, San Diego, CA, USA.
Winson S HoDepartment of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, UT, USA.
Heather M McGeeDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anne MonetteLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Joseph F MurphyCaprion Biosciences Inc, Montreal, QC, Canada.
Paola NisticòIRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy.
Wungki ParkMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Maulik PatelAbbVie, Redwood City, CA, USA.
Michael QuigleyBristol-Myers Squibb Company, Redwood City, CA, USA.
Laszlo RadvanyiOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Harry RaftopoulosBayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.
Nils-Petter RudqvistDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Alexandra SnyderMerck & Co, Kenilworth, NJ, USA.
Randy F SweisUniversity of Chicago, Chicago, IL, USA.
Sara ValpioneCRUK Manchester Institute and The Christie NHS Foundation Trust, The University of Manchester, Manchester, UK.
Roberta ZappasodiLudwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lisa H ButterfieldParker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Mary L DisisUniversity of Washington, Seattle, WA, USA.
Bernard A FoxEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, USA.
Alessandra CesanoNanoString Technologies, Inc, Seattle, WA, USA.
Francesco M MarincolaRefuge Biotechnologies Inc, 1505 Adams Drive, Suite D, Menlo Park, CA, 94025, USA. franco.marincola@refugebiotech.com.
Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MGerm-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibitionR01CA238998 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WEIDHAAS, JOANNE B · 2019 to 2023
$1.8MNCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA238998
Abstract
Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.